Concepedia

Nayeon Kim

NK

Statistics

Publications

9

Citations

247

H-Index

9

Active since

2013

Affiliations

National Cancer Center(Current)

Dongguk University

Korea University

Osong Medical Innovation Foundation

Nayeon Kim is an author at National Cancer Center specializing in medicine, cancer research, and tumor biology.

ORCID

Top concepts

Publications per year

2013–2024

9

Publications

9

Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor

Seon-Hyeong Lee, Nayeon Kim, Se Jin Kim et al. · Journal of Cancer Research and Clinical Oncology · 2013 · 47 citations · Full text

, , +10

The BDNF Val66Met Polymorphism Affects the Vulnerability of the Brain Structural Network

Chang-Hyun Park, Jungyoon Kim, Eun Namgung et al. · Frontiers in Human Neuroscience · 2017 · 44 citations · Full text

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models

Bo Mi Ku, Se-Jin Kim, Nayeon Kim et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 43 citations · Full text

, , +9

Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition

Seon-Hyeong Lee, Won‐Kyu Lee, Nayeon Kim et al. · Cancers · 2018 · 30 citations · Full text

Allosteric inhibition site of transglutaminase 2 is unveiled in the N terminus

Nayeon Kim, Joon Hee Kang, Won‐Kyu Lee et al. · Amino Acids · 2018 · 19 citations · Full text

, , +19

1–5 of 9